Alpha-Synuclein Inhibitors Clinical Trial Pipeline as Novel and Extensive 22+ Therapies Likely to Enter in the Domain | DelveInsight
February 13, 2025 13:00 ET
|
DelveInsight Business Research LLP
New York, USA, Feb. 13, 2025 (GLOBE NEWSWIRE) -- Alpha-Synuclein Inhibitors Clinical Trial Pipeline as Novel and Extensive 22+ Therapies Likely to Enter in the Domain | DelveInsight Alpha-synuclein...
Chronic Pain Clinical Trial Pipeline Experiences Momentum: DelveInsight Estimates a Diverse Pipeline Comprising 20+ Companies Working in the Domain
January 30, 2025 13:00 ET
|
DelveInsight Business Research LLP
New York, USA, Jan. 30, 2025 (GLOBE NEWSWIRE) -- Chronic Pain Clinical Trial Pipeline Experiences Momentum: DelveInsight Estimates a Diverse Pipeline Comprising 20+ Companies Working in the Domain ...
BRAF Inhibitors Market to Register Incremental Growth During the Study Period (2020–2034) | DelveInsight
January 29, 2025 13:00 ET
|
DelveInsight Business Research LLP
New York, USA, Jan. 29, 2025 (GLOBE NEWSWIRE) -- BRAF Inhibitors Market to Register Incremental Growth During the Study Period (2020–2034) | DelveInsight The BRAF Inhibitors market is expected to...
Pulmonary Fibrosis Clinical Trial Pipeline Appears Robust With 110+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight
January 28, 2025 13:00 ET
|
DelveInsight Business Research LLP
New York, USA, Jan. 28, 2025 (GLOBE NEWSWIRE) -- Pulmonary Fibrosis Clinical Trial Pipeline Appears Robust With 110+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight ...
Glioblastoma Market, an Area With High Trial Failure And Unmet Need is Expected to Witness Significant Growth Owing to Increased Usage of Bevacizumab, Temozolimide, Optune Gio Along with Emergence of New Class of Therapies | DelveInsight
January 27, 2025 13:00 ET
|
DelveInsight Business Research LLP
New York, USA, Jan. 27, 2025 (GLOBE NEWSWIRE) -- Glioblastoma Market, an Area With High Trial Failure And Unmet Need is Expected to Witness Significant Growth Owing to Increased Usage of...
Phage Therapies Clinical Trial Pipeline Shows Potential with Active Contributions from 20+ Key Companies | DelveInsight
January 23, 2025 13:00 ET
|
DelveInsight Business Research LLP
New York, USA, Jan. 23, 2025 (GLOBE NEWSWIRE) -- Phage Therapies Clinical Trial Pipeline Shows Potential with Active Contributions from 20+ Key Companies | DelveInsight The phage therapy market is...
5-HT2 Agonist Clinical Trial Pipeline Appears Robust With 20+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight
January 22, 2025 13:00 ET
|
DelveInsight Business Research LLP
New York, USA, Jan. 22, 2025 (GLOBE NEWSWIRE) -- 5-HT2 Agonist Clinical Trial Pipeline Appears Robust With 20+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight ...
Bronchiectasis Market to Show Positive Growth at a CAGR of 13.7% by 2034 | DelveInsight
January 21, 2025 13:00 ET
|
DelveInsight Business Research LLP
New York, USA, Jan. 21, 2025 (GLOBE NEWSWIRE) -- Bronchiectasis Market to Show Positive Growth at a CAGR of 13.7% by 2034 | DelveInsight The bronchiectasis market is expected to experience steady...
Advancements in Ocular Hypertension Clinical Trial Pipeline as 60+ Companies Pave the Way for Future Solutions | DelveInsight
January 20, 2025 13:00 ET
|
DelveInsight Business Research LLP
New York, USA, Jan. 20, 2025 (GLOBE NEWSWIRE) -- Advancements in Ocular Hypertension Clinical Trial Pipeline as 60+ Companies Pave the Way for Future Solutions | DelveInsight The ocular...
Global Exosome Diagnostics Market is Projected to Boom with an Enormous CAGR of ~47% by 2032 | DelveInsight
January 16, 2025 13:00 ET
|
DelveInsight Business Research LLP
New York, USA, Jan. 16, 2025 (GLOBE NEWSWIRE) -- Global Exosome Diagnostics Market is Projected to Boom with an Enormous CAGR of ~47% by 2032 | DelveInsight The rising incidence of cancer is...